Abstract
The histoculture drug response assay (HDRA) with tumors histocultured on GelfoamĀ® was tested for clinical correlation for advanced gastric and colorectal cancer patients. In one study, 29 patients were treated with drugs shown to be ineffective in the HDRA, and all 29 cases showed clinical chemoresistance. In nine patients treated with drugs shown to be effective in the HDRA, six showed clinical chemoresponse and three showed arrest of disease progression. In a study of 32 patients with stage III and IV gastric cancer treated with mitomycin C and 5-fluorouracil (5-FU), the survival rate of 10 patients whose tumors were sensitive to either mitomycin C and/or 5-fluorouracil in the HDRA was significantly better than that of 22 patients whose tumors were insensitive to both drugs in the HDRA. Twenty-nine patients with stage III and IV colorectal cancer without remaining measurable tumor lesions after surgery were treated with fluoropyrimidines adjuvantly. The recurrence-free survival rate of 7 patients whose tumors were sensitive to 5-fluorouracil in the HDRA was significantly better than that of 22 patients whose tumors were insensitive in the HDRA. In a companion study of 128 gastric cancer patients whose tumors were evaluated in the HDRA, the overall and disease-free survival rates of the HDRA-sensitive group were found to be significantly higher than those of the HDRA-resistant group, treated with the same drugs.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lawler EM, Miller FR, Heppner GH (1983) Significance of three-dimensional growth patterns of mammary tissues in collagen gel cultures. In Vitro 19:600ā610
Miller BE, Miller FR, Heppner GH (1984) Assessing tumor drug sensitivity by a new in vitro assay which preserves tumor heterogeneity and subpopulation interactions. J Cell Physiol 3(Suppl):105ā116
Miller BE, Miller FR, Heppner GH (1985) Factors affecting growth and drug sensitivity of mouse mammary tumor lines in collagen gel cultures. Cancer Res 45:4200ā4205
Folkman J, Moscona A (1978) Role of cell shape in growth control. Nature 273(5661):345ā349
Vescio RA, Connors KM, Kubota T, Hoffman RM (1991) Correlation of histology and drug response of human tumors grown in native-state three-dimensional histoculture and in nude mice. Proc Natl Acad Sci U S A 88:5163ā5166
Furukawa T, Kubota T, Hoffman RM (1995) Clinical applications of the histoculture drug response assay. Clin Cancer Res 1:305ā311
Kubota T, Sasano N, Abe O, Nakao I, Kawamura E, Saito T, Endo M, Kimura K, Demura H, Sasano H, Nagura H, Ogawa N, Hoffman RM (1995) Potential of the histoculture drug response assay to contribute to cancer patient survival. Clin Cancer Res 1:1537ā1543
Tanino H, Oura S, Hoffman RM, Kubota T, Furukawa T, Arimoto J, Yoshimasu T, Hirai I, Bessho T, Suzuma T, Sakurai T, Naito Y (2001) Acquisition of multidrug resistance in recurrent breast cancer demonstrated by the histoculture drug response assay. Anticancer Res 21:4083ā4086
Singh B, Li R, Xu L, Poluri A, Patel S, Shaha AR, Pfister D, Sherman E, Hoffman RM, Shah J (2002) Prediction of survival in patients with head and neck cancer using the histoculture drug response assay. Head Neck 24:437ā442
Jung PS, Kim DY, Kim MB, Lee SW, Kim JH, Kim YM, Kim YT, Hoffman RM, Nam JH (2013) Progression-free survival is accurately predicted in patients treated with chemotherapy for epithelial ovarian cancer by the histoculture drug response assay in a prospective correlative clinical trial at a single institution. Anticancer Res 33:1029ā1034
Freeman A, Hoffman RM (1986) In vivo-like growth of human tumors in vitro. Proc Natl Acad Sci U S A 83:2694ā2698
Vescio RA, Redfern CH, Nelson TJ, Ugoretz S, Stern PH, Hoffman RM (1987) In vivo-like drug response of human tumors growing in three-dimensional, gel-supported, primary culture. Proc Natl Acad Sci U S A 84:5029ā5033
Leighton J (1951) A sponge matrix-method for tissue cultures. Formation of organized aggregates of cells in vitro. J Natl Cancer Inst 12:545ā561
Sherwin RP, Richters A, Yellin AE, Donavan AJ (1980) Histoculture of human breast cancers. Surg Oncol 13:9ā20
Hoffman RM (1991) In vitro sensitivity assays in cancer: A review, analysis and prognosis. J Clin Lab Anal 5:133ā143
Hoffman RM (1993) In vitro assays for chemotherapy sensitivity. Crit Rev Oncol Hematol 15:99ā111
Hoffman RM (1991) Three-dimensional histoculture: origins and application in cancer research. Cancer Cells 3:86ā92
Hoffman RM (1993) To do tissue culture in two or three dimensions? That is the question. Stem Cells 11:105ā111
Furukawa T, Kubota T, Watanabe M, Takahara T, Yamaguchi H, Takeuchi T, Kodaira S, Ishibiki K, Kitajima M, Hoffman RM (1992) High in vito-in vitro correlation of drug response using sponge gel-supported three-dimensional histoculture and the MTT end point. Int J Cancer 51:489ā498
Furukawa T, Kubota T, Watanabe M, Kase S, Takahara T, Yamaguchi H, Takeuchi T, Teramoto T, Ishibiki K, Kitajima M, Hoffman RM (1992) Chemosensitivity testing of clinical gastrointestinal cancers using histoculture and the MiT end point. Anticancer Res 12:1377ā1382
Maehara Y, Watanabe A, Kakeji Y, Baba H, Kohnoe S, Sugimachi K (1990) Postgastrectomy prescription of mitomycin C and UFT for patients with stage IV gastric carcinoma. Am J Surg 160:242ā244
Koyama Y, Koyama Y (1980) Phase I study of a new antitumor drug, I-hexylcarbamoyl-5-fluorouracil (HCFU) administered orally: an HCFU clinical study group report. Cancer Treat Rep 64:861ā867
Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457ā481
Ji WB, Um JW, Ryu JS, Hong KD, Kim JS, Min BW, Joung SY, Lee JH, Kim YS (2017) Clinical significance of 5-fluorouracil chemosensitivity testing in patients with colorectal cancer. Anticancer Res 37:2679ā2682
Yano S, Zhang Y, Miwa S, Tome Y, Hiroshima Y, Uehara F, Yamamoto M, Suetsugu A, Kishimoto H, Tazawa H, Zhao M, Bouvet M, Fujiwara T, Hoffman RM (2014) Spatial-temporal FUCCI imaging of each cell in a tumor demonstrates locational dependence of cell cycle dynamics and chemoresponsiveness. Cell Cycle 13:2110ā2119
Von Hoff DD (1990) Selection of cancer chemotherapy for a patient by an in vitro assay versus a clinician. J Natl Cancer Inst 82:110ā116
Gazdar AF, Steinberg SM, Russell EK, Linnoila RI, Oie HK, Ghosh BC, Cotelingham JD, Johnson BE, Minna JD, Ihde DC (1990) Correlation of in vitro drug-sensitivity testing results with response to chemotherapy and survival in extensive-stage small cell lung cancer: a prospective clinical trial. J Natl Cancer Inst 82:117ā124
Leone LA, Meitner PA, Myers TJ, Grace WR, Gajewski WH, Fingert HJ, Rotman B (1991) Predictive value of the fluorescent cytoprint assay (FCA): a retrospective correlation study of in vitro chemosensitivity and individual responses to chemotherapy. Cancer Investig 9:491ā503
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
Ā© 2018 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Hoffman, R.M. (2018). Clinical Correlation of the Histoculture Drug Response Assay in Gastrointestinal Cancer. In: Hoffman, R. (eds) 3D Sponge-Matrix Histoculture. Methods in Molecular Biology, vol 1760. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7745-1_7
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7745-1_7
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7743-7
Online ISBN: 978-1-4939-7745-1
eBook Packages: Springer Protocols